Nate Crossett

Stock Analyst at Exane BNP Paribas

(1.94)
# 3,065
Out of 4,944 analysts
38
Total ratings
50%
Success rate
0.6%
Average return

Stocks Rated by Nate Crossett

Medical Properties Trust
Mar 12, 2025
Upgrades: Outperform
Price Target: $5$9
Current: $4.13
Upside: +117.92%
Omega Healthcare Investors
Feb 8, 2024
Upgrades: Neutral
Price Target: $30
Current: $40.40
Upside: -25.74%
Agree Realty
Dec 13, 2023
Downgrades: Neutral
Price Target: $64
Current: $72.27
Upside: -11.44%
NETSTREIT
Dec 13, 2023
Downgrades: Neutral
Price Target: $17
Current: $18.87
Upside: -9.91%
Realty Income
Dec 13, 2023
Upgrades: Outperform
Price Target: $63
Current: $57.89
Upside: +8.83%
Alexandria Real Estate Equities
Oct 11, 2023
Initiates: Neutral
Price Target: $108
Current: $74.98
Upside: +44.04%
Ventas
Oct 11, 2023
Initiates: Outperform
Price Target: n/a
Current: $68.01
Upside: -
Digital Realty Trust
Jul 28, 2023
Upgrades: Outperform
Price Target: $138
Current: $168.58
Upside: -18.14%
Prologis
Jul 20, 2023
Upgrades: Outperform
Price Target: $141
Current: $106.19
Upside: +32.78%
Gaming and Leisure Properties
Jun 14, 2023
Initiates: Outperform
Price Target: $63
Current: $46.25
Upside: +36.22%
Initiates: Underperform
Price Target: $42
Current: $41.61
Upside: +0.94%
Initiates: Outperform
Price Target: $41
Current: $33.00
Upside: +24.24%
Initiates: Outperform
Price Target: $29
Current: $30.45
Upside: -4.76%
Initiates: Underperform
Price Target: $74
Current: $65.73
Upside: +12.58%
Initiates: Outperform
Price Target: n/a
Current: $15.39
Upside: -
Initiates: Underperform
Price Target: $9.6
Current: $7.67
Upside: +25.16%
Initiates: Outperform
Price Target: $66
Current: $93.97
Upside: -29.76%
Initiates: Outperform
Price Target: $38
Current: $14.98
Upside: +153.67%
Initiates: Outperform
Price Target: $886
Current: $784.00
Upside: +13.01%
Downgrades: Hold
Price Target: $31$30
Current: $25.47
Upside: +17.79%
Initiates: Buy
Price Target: $21
Current: $16.05
Upside: +30.84%
Downgrades: Hold
Price Target: $21$25
Current: $8.98
Upside: +178.40%
Upgrades: Buy
Price Target: n/a
Current: $33.92
Upside: -